1983
DOI: 10.1097/00132582-198312000-00011
|View full text |Cite
|
Sign up to set email alerts
|

Placental Transfer of Dantrolene

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
3
0
2

Year Published

1987
1987
2019
2019

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(5 citation statements)
references
References 0 publications
0
3
0
2
Order By: Relevance
“…In two small case series involving pregnant women, dantrolene crossed the placenta but caused no apparent harm to the mothers or the neonates. Neonatal dantrolene serum concentrations were 40-70 % those of the mothers [49,50]. Dantrolene also has been detected in breast milk of a mother who was being treated for malignant hyperthermia after an emergency cesarean section.…”
Section: Pregnant and Breast-feeding Patientsmentioning
confidence: 98%
See 1 more Smart Citation
“…In two small case series involving pregnant women, dantrolene crossed the placenta but caused no apparent harm to the mothers or the neonates. Neonatal dantrolene serum concentrations were 40-70 % those of the mothers [49,50]. Dantrolene also has been detected in breast milk of a mother who was being treated for malignant hyperthermia after an emergency cesarean section.…”
Section: Pregnant and Breast-feeding Patientsmentioning
confidence: 98%
“…The intracompartment distribution halflife (t 1/2a ) was 1.6 min [48]. Dantrolene crosses the placenta in humans with a fetal-to-maternal serum concentration ratio of 0.4-0.7 [49,50].…”
Section: Pharmacokineticsmentioning
confidence: 99%
“…Revista Neurociências V13 N3 (supl-versão eletrônica) Dantrolene foi quantificado em 1,39 µg.ml -1 no sangue venoso do cordão umbilical de recém nascidos sem demonstrar efeitos colaterais (Morison, 1983). Concentração sérica…”
Section: Neurociênciasunclassified
“…O uso de dantrolene em gestantes resultou em relação plasmática fetal-materna de 0,4 mg.dl-1 e a secreção de dantrolene no leite materno foi confirmada 36 h após administração, com meia vida (T½) no leite materno de 9,02 h sugerindo segurança para o recém nascido na amamentação após 2 dias do término da administração do dantrolene intravenoso 28,29 .…”
Section: Farmacocinéticaunclassified